Rodino Peter W. III

Avg. Two Year Performance

(53%) Avg. Purchase Return
(24%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)(42%)(79%)(43%)(53%)
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

COO, Secretary, Gen. Counsel:

Holdings: 181.72K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--